Castle Biosciences Inc (CSTL)

R&D Expense Growth

0.80%

Quarterly · Period ending:

CSTL logo

CSTL R&D Expense Growth

Latest reported0.80%
CSTL Quarterly R&D Growth (QoQ) (0.00% → 0.80%)
High-resolution chart · PNG

CSTL r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Castle Biosciences Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
0.7971%
6.7555%
4.2824%
1.3529%
1.5809%
7.8017%
-5.2422%
-12.8254%
2.368%
6.2721%
0.5494%
-2.893%
-7.5384%
27.2703%
3.6857%
-8.5444%
10.8261%
13.9333%
25.9333%
10.4078%
14.9797%
28.9675%
49.8038%
13.0917%
-7.1747%
-7.7857%
108.516%
15.0109%
-5.4966%
22.4778%
-12.0727%
11.655%
-8.1962%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.